Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
October 27, 2017
MediWound Announces Exercise of Underwriters’ Option to Purchase Additional Shares
YAVNE, Israel, Oct. 27, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (MDWD), a fully-integrated biopharmaceutical company specializing in innovative therapies to address unmet needs in severe ...
October 26, 2017
Prometic receives clearance from the Swedish Medical Products Agency to initiate plasminogen diabetic foot ulcer Phase 2 clinical trial
LAVAL, QC , Oct.  26, 2017 /CNW Telbec/ - Prometic Life Sciences Inc. (PLI.TO) (PFSCF) (Prometic) today announced that it has received Swedish Medical Products Agency (MPA) ...
October 26, 2017
Intec Pharma Names Walt Linscott as Chief Administrative Officer
JERUSALEM, October 26, 2017 /PRNewswire/ -- Intec Pharma Ltd. (NTEC) (NTEC.TA), a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill™ platform technology, ...
October 26, 2017
iCAD’s PowerLook Tomo Detection for Digital Breast Tomosynthesis Named 2017 Product of the Year by New Hampshire High Technology Council
NASHUA, N.H., Oct. 26, 2017 (GLOBE NEWSWIRE) -- iCAD, Inc. (ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification ...
October 26, 2017
Catalyst Biosciences Announces the Appointment of Industry Veteran Andrea Hunt to its Board of Directors
SOUTH SAN FRANCISCO, Calif., Oct. 26, 2017 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address ...
October 26, 2017
Pernix Therapeutics to Report Third Quarter 2017 Financial Results on Tuesday, November 7
MORRISTOWN, N.J., Oct. 26, 2017 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (PTX) (“Pernix” or the “Company”), a specialty pharmaceutical company, announced today that the ...
October 26, 2017
Arcturus Therapeutics Announces Presentations at Conferences in November
SAN DIEGO, Oct. 26, 2017 (GLOBE NEWSWIRE) -- Arcturus Therapeutics, Inc., a leading RNA medicines company, announced today that it plans to present at three ...
October 26, 2017
Achaogen Submits Plazomicin New Drug Application (NDA) to the U.S. FDA for Treatment of Complicated Urinary Tract Infections and Bloodstream Infections
SOUTH SAN FRANCISCO, Calif., Oct. 26, 2017 (GLOBE NEWSWIRE) -- Achaogen, Inc. (AKAO), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram-negative ...
October 26, 2017
Heron Therapeutics Granted FDA Fast Track Designation for HTX-011 to Reduce Postoperative Pain and the Need for Opioid Analgesics for 72 Hours
SAN DIEGO--(BUSINESS WIRE) -- Heron Therapeutics, Inc. (HRTX) (the Company or Heron), a commercial-stage biotechnology company focused on developing novel best-in-class treatments to address some ...
October 26, 2017
AIT Therapeutics Strengthens Executive Team with Three Key Senior Hires as Company Prepares for Upcoming Clinical Milestones
NEW YORK, Oct. 26, 2017 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. (AITB), a clinical-stage biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the ...
October 26, 2017
UroGen Pharma Expands Leadership Team, Appoints Industry Veterans Jeffrey Bova as Vice President of Commercial and James Ottinger as Vice President of Regulatory Affairs
RA’ANANA, Israel, and NEW YORK, Oct. 26, 2017 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs ...
October 26, 2017
VBI Vaccines Prices Concurrent Public Offering and Registered Direct Offering for Aggregate Proceeds of $63.5 Million
CAMBRIDGE, Mass., Oct. 26, 2017 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (VBIV) (VBV.TO) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today ...
October 25, 2017
Paratek Pharmaceuticals to Report Third Quarter 2017 Financial Results and Provide Update on Clinical Progress on November 8, 2017
BOSTON, Oct. 24, 2017 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon ...
October 25, 2017
AIT Therapeutics Announces Third Quarter Financial Results Conference Call/Webcast
NEW YORK, Oct. 24, 2017 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. (AITB), a clinical stage anti-microbial therapeutic company treating respiratory diseases with nitric oxide (NO), ...
October 25, 2017
Sierra Oncology Appoints Dr. Andrew Allen to its Board of Directors
VANCOUVER, Oct. 25, 2017 /PRNewswire/ - Sierra Oncology, Inc. (SRRA), a clinical stage drug development company focused on advancing next generation DNA Damage Response (DDR) therapeutics for the ...
October 25, 2017
Prometic Receives Fast Track Designation for PBI-4050 in Development for Idiopathic Pulmonary Fibrosis (IPF)
LAVAL, QC , Oct. 25, 2017 /CNW/ - Prometic Life Sciences Inc. (PLI.TO) (PFSCF) (Prometic) today announced that the U.S. Food and Drug Administration (FDA) has granted ...
October 25, 2017
MediWound Appoints Mr. Stephen T. Wills as Chairman to its Board of Directors
YAVNE, Israel, Oct. 25, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (MDWD), a fully-integrated biopharmaceutical company specializing in innovative therapies to address unmet needs in severe ...
October 25, 2017
Rockwell Update on Calcitriol Post-Approval Manufacturing Submission to FDA
WIXOM, Mich., Oct. 25, 2017 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (RMTI), today provided an update on the commercial launch of Calcitriol, stating that the ...
October 24, 2017
CymaBay to Host Post-AASLD Key Opinion Leader Meeting on Novel Treatments for Primary Biliary Cholangitis
NEWARK, Calif., Oct. 23, 2017 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic ...
October 24, 2017
AC Immune to Present at Two Investor Conferences and Provide Scientific Updates at CTAD Conference
Lausanne, Switzerland, - October 24, 2017 -   AC Immune SA (ACIU), a Swiss-based, clinical stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, today ...
Page 84 of 117